{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:40:52Z","timestamp":1763534452048,"version":"3.45.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neutralizing antibodies (NAbs) are critical for protection against SARS-CoV-2, but there is limited information on their role in pregnancy, especially among Cameroonian women. Here, we aimed to determine the prevalence of pan-coronavirus reactive antibodies from pregnant women sampled before and during the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma samples from 629 women in the second trimester and 661 at delivery were collected pre-COVID-19 and from 39 women at delivery during COVID-19 in Yaound\u00e9, Cameroon. All samples were screened using the Abbott Panbio\u2122 COVID-19 rapid diagnostic test (RDT). Enzyme-linked immunosorbent assays (ELISA) and the spike-pseudotyped lentivirus neutralization assay were done to measure antibody binding and neutralizing capacity in 118 and 33 samples, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Before the pandemic, 16.5% (213\/1290) of pregnant women were seropositive for cross-reactive anti-SARS-CoV-2 antibodies by RDT, while 12.2% (11\/90) were seropositive to antibody binding by ELISA. Additionally, no correlation was found between cross-reactivity against the spike protein of SARS-CoV-2 and the HCoVs-OC43 and HcoVs-NL63 spikes. However, during the pandemic, 53.8% (21\/39) of women sampled at delivery were seropositive by RDT, all women (28\/28-100%) were seropositive by ELISA and 90% (20\/22) of the samples from pregnant women tested for neutralization (20\/22) had detectable neutralizing antibody responses during the COVID-19 pandemic. A transplacental transfer of binding antibodies from the mother to the child was found in 76.9% (30\/39) of the tested dyads with a high prevalence during pandemic (26\/28-86.7%) than prior the pandemic (4\/11-13.3%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study goes to reinforce the need for vaccination as though, all participants elicited a response towards endemic coronaviruses before the COVID-19 pandemic, a very small fraction of participants had binding antibodies which cross-react with SARS-CoV-2 and none of these were neutralizing. Anti-SARS-CoV-2 antibodies from the studied pregnant Cameroonian women at delivery during the pandemic had neutralizing activity against the founder variant and were efficiently transferred to the newborn. However the neutralization against other variants of concern warrants future investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1628102","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:35:38Z","timestamp":1763534138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transplacental transferred anti-SARS-CoV-2 neutralizing antibodies in unvaccinated pregnant women in Cameroon occurred during the COVID-19 pandemic, but not in the pre-pandemic period"],"prefix":"10.3389","volume":"16","author":[{"given":"Reine Medouen Ndeumou","family":"Seumko\u2019o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thandeka","family":"Moyo-Gwete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tandile","family":"Hermanus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosthene Hillary Matabou","family":"Tene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romeo Brice Dieffouo","family":"Djounda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris Marco Mbianda","family":"Nana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard Marie Zambo","family":"Bitye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tekougang Berenice Kenfack","family":"Zangue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodin Darcisse Kwanou","family":"Tchakounte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitel Mpoudi","family":"Ngolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane Wallace","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose Gana Fomban","family":"Leke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosette","family":"Megnekou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livo Forgu","family":"Esemu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06540-11","article-title":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus","volume":"86","author":"Woo","year":"2012","journal-title":"J Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06632-2","article-title":"Genomic evolution of the human and animal coronavirus diseases","volume":"48","author":"Miranda","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00604-z","article-title":"On the origin and evolution of SARS-CoV-2","volume":"53","author":"Singh","year":"2021","journal-title":"Exp Mol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e044149","DOI":"10.1136\/bmjopen-2020-044149","article-title":"COVID-19 in West Africa: national projections of total and severe infections under different lockdown scenarios","volume":"11","author":"Frost","year":"2021","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/d41591-020-00004-2","article-title":"Nigeria responds to COVID-19; first case detected in sub-Saharan Africa","volume":"26","author":"Adepoju","year":"2020","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30373-X","article-title":"COVID-19 in Cameroon: a crucial equation to resolve","volume":"20","author":"Mbopi-Keou","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/v14102259","article-title":"Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African Populations","volume":"14","author":"Souris","year":"2022","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155855","article-title":"Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status","volume":"14","author":"Aissatou","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00636-10","article-title":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method","volume":"48","author":"Gaunt","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085953","article-title":"The Genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45561-0","article-title":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection","volume":"53","author":"Chen","year":"2004","journal-title":"J Med Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03897-6","article-title":"Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening","volume":"39","author":"Zhao","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.08.038","article-title":"Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis","volume":"228","author":"Smith","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100118","DOI":"10.1016\/j.ajogmf.2020.100118","article-title":"Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals","volume":"2","author":"Breslin","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1038\/s41467-021-25946-0","article-title":"SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon","volume":"12","author":"Nwosu","year":"2021","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4269\/ajtmh.2010.10-0249","article-title":"Longitudinal studies of plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission","volume":"83","author":"Leke","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237671","article-title":"Antibodies to full-length and the DBL5 domain of VAR2CSA in pregnant women after long-term implementation of intermittent preventive treatment in Etoudi, Cameroon","volume":"15","author":"Djontu","year":"2020","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"crossref","unstructured":"Comparative Performance of Serological (IgM\/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic\n          \n          \n            \n              Kamga Wouambo\n              R\n            \n            \n              Djuikou\u00e9\n              CI\n            \n            \n              Esemu\n              LF\n            \n            \n              Kagoue Simeni\n              LA\n            \n            \n              Tchitchoua\n              MC\n            \n            \n              Djouela Djoulako\n              PD\n            \n          \n          10.3390\/v15020407\n          36851621\n          Viruses\n          15\n          2023","DOI":"10.3390\/v15020407"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"B23","article-title":"SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies","author":"Moyo-Gwete","year":"2021","journal-title":"BioRxiv Prepr Serv Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: A detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.chom.2022.03.029","article-title":"SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals","volume":"30","author":"Richardson","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.07.20245431","article-title":"Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials","volume":"59","author":"Sholukh","year":"2020","journal-title":"MedRxiv Prepr Serv Health Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01605-6","article-title":"COVID-19 research in LMICs","volume":"398","author":"Sisa","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1097\/OGX.0000000000000510","article-title":"Anemia in pregnancy: a pragmatic approach","volume-title":"Obstet Gynecol Surv.","author":"Sun","year":"2017"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.104","article-title":"High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa","volume":"102","author":"Tso","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00039\/full","article-title":"The role of pregnancy-associated hormones in the development and function of regulatory B cells","volume":"5","author":"Muzzio","year":"2014","journal-title":"Front Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.11.008","article-title":"Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam","volume":"139","author":"Nguyen","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.09.005","article-title":"High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic","author":"Mansuy","year":"2023","journal-title":"Public Health"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3201\/eid2806.212580","article-title":"Rapid increase of community SARS-CoV-2 seroprevalence during second wave of COVID-19, yaound\u00e9, Cameroon","volume":"28","author":"Ndongo","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1038\/s41598-024-55989-4","article-title":"Neutralizing immunity against coronaviruses in Tanzanian health care workers","volume":"14","author":"Barabona","year":"2024","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12879-024-09399-6","article-title":"Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women","volume":"24","author":"Vercoutere","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac793","article-title":"Maternal antibody response and transplacental transfer following severe acute respiratory syndrome coronavirus 2 infection or vaccination in pregnancy","volume":"76","author":"Otero","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamapediatrics.2021.0038","article-title":"Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004440","article-title":"Maternal antibody response, neutralizing potency, and placental antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"138","author":"Joseph","year":"2021","journal-title":"Obstet Gynecol"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105495","article-title":"Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies","volume-title":"J Clin Virol.","author":"Brebant","year":"2023"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1628102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:35:42Z","timestamp":1763534142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1628102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2025.1628102"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1628102","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"article-number":"1628102"}}